01 July 1996
Caffeine clearance in patients with primary biliary cirrhosis
Frantisek Perlik, Martin Gilar, Marie BrodanovaMed Sci Monit 1996; 2(4): CR457-460 :: ID: 499946
Abstract
The clinical value and the sensitivity of saliva caffeine clearance measurement was evaluated as an indicator of liver metabolic capacity in patients with primary biliary cirrhosis (PBC). Saliva test was performed in 12 female patients with PBC and 8 healthy female volunteers. After a 48 hour caffeine exclusion period two doses of 140 mg of caffeine separated by a 4 hour interval were administered orally. Saliva samples were taken 6 and 14 hours later. Caffeine concentrations were measured by high-performance liquid chromatography. Pharmacokinetic parameters were calculated by the fitting procedure of the Bayesian feedback method. There was a significant increase of caffeine half-life in patients with PBC with the mean (SD) value of 5.47 (1.33) hours as compared to that in healthy controls - 4.5 (0.69) hours. The correlation between the pharmacokinetic parameters of caffeine (half-life, clearance and volume of distribution) was statistically significant (p < 0.05) both with the prothrombin ratio and staging, based on morphologic findings in the PBC group. There was no significant correlation neither between the pharmacokinetic parameters of caffeine and conventional liver function tests, nor between the pharmacokinetic parameters and galactose elimination capacity (GEC). Our results suggest that caffeine clearance, like GEC, quantitates a very particular enzymatic reaction which may not be representative for the functional capacity of the entire organ. Thus, a simplified caffeine clearance test represents a helpful additional criterion for the assessment of hepatic function in patients with PBC.
Keywords: primary biliary cirrhosis, caffeine clearance, Bayesian estimate
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952